Immunoassay Market Size, Share, Statistics, Trend Analysis and Forecast Report, 2022 - 2032

Immunoassay Market is segmented by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay Analyzers, Software & Services), Platform (Chemiluminescence, Radioimmunoassay), Application (Infectious Diseases, Oncology, Allergy), End User and Geography.

  • Report ID : MD2817
  • |
  • Pages : 220
  • |
  • Tables : 70
  • |
  • Formats :

The Immunoassay Market is projected to reach a market size value of USD 46.5 billion by 2028, at a CAGR of 7.5% during the forecast period of 2021 to 2028.

Immunoassay is a test to determine a specific type of antibody present in your system as well as antigens found in the blood and other bodily fluids. This procedure can determine and characterize a disease by using an antibody that will adhere to the antigen. The factors attributed to the growth of this market are, the emergence of acute and chronic infectious diseases along with the increasing old-aged population, early diseases diagnosis awareness, innovations in immunoassays, high demand application of immunoassays in oncology, drug and alcohol examinations, and the abrupt effects of COVID-19.

The most known immunoassay technique used for the diagnosis of infectious diseases is ELISA. This is done by measuring antibodies, antigens, proteins, and glycoproteins.
Aside from the above mentioned factors, there are others that is seemingly contributing to the emergence of immunoassay market. These are, the numerous epidemic potentials being discovered, introduction of microfluids technology, and emerging economies in certain regions.

COVID-19 Analysis

There are perverse results brought upon by the pandemic because of the lock downs and implemented protocols which may have disrupted the supply chain, distribution and manufacturing in facilities of prominent companies. This can be considered a big set back in the growth of the immunoassay market because if manufacturing and distribution of raw materials supply are affected, production and sales will also be negatively affected making it challenging for these companies to meet demands of end users. The pandemic demanded an immediate response of action from health institutes and governments to contain the spread by identifying the infected by means of early diagnosis. With the fast transmission and progression of the virus, molecular diagnostics tests or PCR cannot easily be utilized to track development of the disease unlike immunological assays.

Key Findings of the Global Immunoassays Market

In terms of immunoassay kits and reagents segment, the ELISA kits and reagents segment is projected to have the largest share during the forecast period accounted for. This is mainly because of the rising number of infectious diseases like HIV, being aware on diagnosing cancer and autoimmune diseases at an early phase, and the threats brought upon by the COVID-19 virus.

In terms of platform, during the forecast period, the chemiluminescence immunoassays segment is anticipated to grow at the highest CAGR. Factors such as increasing trends in adoption of chemiluminescence assays in diagnosis, applications in research, and inexpensive pharmaceutical analysis causes the growth in this segment.

In terms of application, the bone and mineral diseases segment is also projected to have the highest CAGR growth during the forecast period. Main factors attributing to such growth are, high demands in diagnosing osteoporosis in its early phase, treatment monitoring, and the increasing demand for vitamin D testing.

In terms of end user, the diagnostic reference laboratories segment is anticipated to have the largest share in the immunoassay market in 2021 because of automation in laboratories, well-equipped systems are easily accessible, emergence and increase in the number of infectious diseases, and increase in the adoption and application of immunoassay techniques because of government initiatives promoting and funding it.

Regional Market Analysis

In terms of region, the North America segment is projected to have the largest share accounted for in the immunoassay market in 2021. Asia Pacific on the other hand, is anticipated to have a rapid CAGR growth in 2021-2028. the growth in this region is driven by factors like, increasing number of infectious diseases and cancer emergence, prevalence of government funding and initiatives with respect to improving healthcare system, and easily accessible diagnostic tests and treatments for patients suffering from infectious diseases.

Key Players: Share and Competition

Based on an extensive assessment, these major key players in the Immunoassay Market have a competitive landscape and utilizing key strategic developments to lead the industry over the past years until now. These companies are, F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.) and PerkinElmer, Inc. (U.S.)

Report Highlights
• Historical data available (as per request)
• Estimation/projections/forecast for revenue and unit sales (2021 – 2028)
• Data breakdown for every market segment (2021 – 2028)
• Gross margin and profitability analysis of companies
• Price analysis of each product type
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategy

Industry Segmentation and Revenue Breakdown

Product & Solution Analysis (Revenue, USD Million, 2021 - 2028)

• Immunoassay Kits and Reagents
• Elisa Kits and Reagents
• Rapid Test Kits and Reagents
• Western Blot Kits and Reagents
• Elispot Kits and Reagents
• Other Immunoassay Kits and Reagents
• Immunoassay Analyzers
• Immunoassay Software and Services
(Other immunoassay kits and reagents comprises radioimmunoassay, microarray immunoassays, immunohistochemistry assays, bead-based immunoassays, and multiplex microarray assays)

Platform Analysis (Revenue, USD Million, 2021 - 2028)

• Chemiluminescence Immunoassay
• Fluorescence Immunoassay
• Colorimetric Immunoassay
• Radioimmunoassay
• Other Immunoassay Platforms
(Other immunoassay platforms comprise turbidimetric immunoassays, chromatographic immunoassays, microarray immunoassays, immunohistochemistry, and counting immunoassays)

Application Analysis (Revenue, USD Million, 2021 - 2028)

• Infectious Diseases
• Oncology
• Endocrinology
• Cardiology
• Bone and Mineral Diseases
• Autoimmune Disorders
• Other Applications
(Other applications comprise toxicology, hematology, neonatal testing, allergy, and gastrology.)

End User Analysis (Revenue, USD Million, 2021 - 2028)

• Diagnostics Reference Laboratories
• Hospitals and Clinics
• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Other End Users
(Other end users comprise nursing homes, ambulatory care centers, blood banks, and home healthcare agencies)

Region Analysis (Revenue, USD Million, 2020 – 2028)

• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• Qatar
• Saudi Arabia
• Japan
• Africa
• Rest of World

Available Versions:
• United States Immunoassay Industry Research Report
• Europe Immunoassay Industry Research Report
• Asia Pacific Immunoassay Industry Research Report

Need report on this market for specific region or Country? Or need a customized report as per your need? Want to know discounts as available?

Email US

David Correa

Or Fill the form below "Sample Request Form" with your queries in message box.


20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail